Insider Stock Trading History of Ratliff John D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ratliff John D since year 2005. The trader's CIK number is 1575951. At the time of this reporting, Ratliff John D is the CEO, Covance Drug Development of Laboratory Corp Of America Holdings . (stock ticker symbol LH). See this page for all insider trading activities at Laboratory Corp Of America Holdings .

Note that in the past Ratliff John D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ratliff John D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-09 LH Laboratory Corp Of America Holdings Option Ex 6,100 .00 0
2013-11-18 Q Quintiles Transnational Holdings Inc. Sale 212,140 42.55 9,026,557

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ratliff John D (CEO, Covance Drug Development of Laboratory Corp Of America Holdings at the time of this reporting) see the Securities and Exchange Commission (SEC) website.